188 related articles for article (PubMed ID: 28771772)
1. Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.
El Ansari R; McIntyre A; Craze ML; Ellis IO; Rakha EA; Green AR
Histopathology; 2018 Jan; 72(2):183-190. PubMed ID: 28771772
[TBL] [Abstract][Full Text] [Related]
2. Glutamine metabolism in breast cancer and possible therapeutic targets.
Li S; Zeng H; Fan J; Wang F; Xu C; Li Y; Tu J; Nephew KP; Long X
Biochem Pharmacol; 2023 Apr; 210():115464. PubMed ID: 36849062
[TBL] [Abstract][Full Text] [Related]
3. Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism.
Budczies J; Brockmöller SF; Müller BM; Barupal DK; Richter-Ehrenstein C; Kleine-Tebbe A; Griffin JL; Orešič M; Dietel M; Denkert C; Fiehn O
J Proteomics; 2013 Dec; 94():279-88. PubMed ID: 24125731
[TBL] [Abstract][Full Text] [Related]
4. Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer.
Trilla-Fuertes L; Gámez-Pozo A; López-Camacho E; Prado-Vázquez G; Zapater-Moros A; López-Vacas R; Arevalillo JM; Díaz-Almirón M; Navarro H; Maín P; Espinosa E; Zamora P; Fresno Vara JÁ
BMC Cancer; 2020 Apr; 20(1):307. PubMed ID: 32293335
[TBL] [Abstract][Full Text] [Related]
5. Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.
Cha YJ; Kim ES; Koo JS
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562706
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Footprints and Molecular Subtypes in Breast Cancer.
Cappelletti V; Iorio E; Miodini P; Silvestri M; Dugo M; Daidone MG
Dis Markers; 2017; 2017():7687851. PubMed ID: 29434411
[TBL] [Abstract][Full Text] [Related]
7. Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.
van Geldermalsen M; Quek LE; Turner N; Freidman N; Pang A; Guan YF; Krycer JR; Ryan R; Wang Q; Holst J
BMC Cancer; 2018 Jun; 18(1):689. PubMed ID: 29940911
[TBL] [Abstract][Full Text] [Related]
8. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
[TBL] [Abstract][Full Text] [Related]
9. Glutamate enrichment as new diagnostic opportunity in breast cancer.
Budczies J; Pfitzner BM; Györffy B; Winzer KJ; Radke C; Dietel M; Fiehn O; Denkert C
Int J Cancer; 2015 Apr; 136(7):1619-28. PubMed ID: 25155347
[TBL] [Abstract][Full Text] [Related]
10. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
[TBL] [Abstract][Full Text] [Related]
11. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
Simpson NE; Tryndyak VP; Beland FA; Pogribny IP
Breast Cancer Res Treat; 2012 Jun; 133(3):959-68. PubMed ID: 22101407
[TBL] [Abstract][Full Text] [Related]
12. Metabolic characterization of triple negative breast cancer.
Cao MD; Lamichhane S; Lundgren S; Bofin A; Fjøsne H; Giskeødegård GF; Bathen TF
BMC Cancer; 2014 Dec; 14():941. PubMed ID: 25495193
[TBL] [Abstract][Full Text] [Related]
13. IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
Venmar KT; Kimmel DW; Cliffel DE; Fingleton B
Biochim Biophys Acta; 2015 May; 1853(5):1219-28. PubMed ID: 25746764
[TBL] [Abstract][Full Text] [Related]
14. The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
Youngblood VM; Kim LC; Edwards DN; Hwang Y; Santapuram PR; Stirdivant SM; Lu P; Ye F; Brantley-Sieders DM; Chen J
Cancer Res; 2016 Apr; 76(7):1825-36. PubMed ID: 26833123
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells.
Meadows AL; Kong B; Berdichevsky M; Roy S; Rosiva R; Blanch HW; Clark DS
Biotechnol Prog; 2008; 24(2):334-41. PubMed ID: 18307352
[TBL] [Abstract][Full Text] [Related]
16. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
[TBL] [Abstract][Full Text] [Related]
17. Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism.
Cacace A; Sboarina M; Vazeille T; Sonveaux P
Oncogene; 2017 Apr; 36(15):2074-2084. PubMed ID: 27748760
[TBL] [Abstract][Full Text] [Related]
18. Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.
Sun X; Stewart DA; Sandhu R; Kirk EL; Pathmasiri WW; McRitchie SL; Clark RF; Troester MA; Sumner SJ
PLoS One; 2018; 13(4):e0193792. PubMed ID: 29668675
[TBL] [Abstract][Full Text] [Related]
19. Potential Therapeutic Targets in Energy Metabolism Pathways of Breast Cancer.
Islam RA; Hossain S; Chowdhury EH
Curr Cancer Drug Targets; 2017; 17(8):707-721. PubMed ID: 28359244
[TBL] [Abstract][Full Text] [Related]
20. Glutamine Metabolism in Cancer.
Li T; Le A
Adv Exp Med Biol; 2018; 1063():13-32. PubMed ID: 29946773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
